Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SAP25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TMCO5A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ADAM8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OBSL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ANO9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF783 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DAGLB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YBEY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS9D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL11A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MICALL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPK8IP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GFRA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NTN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLDN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC34A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on